|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 79.41 USD | +1.28% |
|
-1.85% | -36.01% |
| 12-09 | Canaccord Genuity Adjusts Price Target on DexCom to $99 From $89, Keeps Buy Rating | MT |
| 12-03 | Wall Street: stable, but the Nasdaq sets a new record | CF |
| Capitalization | 30.63B 29.09B 27.02B 23.99B 43.42B 2,599B 48.02B 336B 124B 1,067B 115B 112B 4,653B | P/E ratio 2024 * |
51x | P/E ratio 2025 * | 40.7x |
|---|---|---|---|---|---|
| Enterprise value | 32.11B 30.5B 28.33B 25.15B 45.52B 2,725B 50.35B 352B 130B 1,119B 121B 118B 4,879B | EV / Sales 2024 * |
8x | EV / Sales 2025 * | 6.81x |
| Free-Float |
95.24% | Yield 2024 * |
-
| Yield 2025 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: DexCom, Inc.
More recommendations
More press releases
More news
| 1 day | +1.28% | ||
| 1 week | +0.13% | ||
| Current month | +1.82% | ||
| 1 month | +13.51% | ||
| 3 months | +13.91% | ||
| 6 months | -31.42% | ||
| Current year | -36.01% |
1 week
77.33
82.26
1 month
69.2382.26
Current year
62.34142.00
1 year
62.34142.00
3 years
62.34144.96
5 years
45.52164.86
10 years
10.66164.86
| Director | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CEO | Chief Executive Officer | 66 | 2014-12-31 |
Jereme Sylvain
DFI | Director of Finance/CFO | 44 | 2021-03-18 |
| Chief Tech/Sci/R&D Officer | 47 | 2022-09-30 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kevin Sayer
CHM | Chairman | 66 | 2018-07-29 |
Eric Topol
BRD | Director/Board Member | 69 | 2009-07-08 |
Nick Augustinos
BRD | Director/Board Member | 65 | 2009-11-19 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.46% | 20 M€ | +16.38% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +1.28% | +0.13% | -32.11% | -43.29% | 30.63B | ||
| +0.52% | -1.12% | +10.52% | -12.85% | 199B | ||
| -0.45% | -3.42% | +5.33% | -25.91% | 108B | ||
| -0.70% | -0.62% | -4.67% | -9.66% | 64.48B | ||
| +0.59% | +4.40% | +22.10% | +11.97% | 46.68B | ||
| -1.46% | -5.15% | +17.48% | +94.77% | 46.49B | ||
| -1.79% | -1.37% | +28.17% | +26.43% | 30.2B | ||
| -0.90% | -1.05% | -6.71% | -25.61% | 23.33B | ||
| -0.98% | -1.90% | -7.59% | -13.58% | 21.79B | ||
| -0.65% | -2.12% | +6.84% | -7.81% | 21.28B | ||
| Average | -0.45% | -0.90% | +3.94% | -0.56% | 59.18B | |
| Weighted average by Cap. | -0.17% | -1.54% | +6.60% | -4.39% |
| 2024 * | 2025 * | |
|---|---|---|
| Net sales | 4.02B 3.81B 3.54B 3.15B 5.69B 341B 6.3B 44.04B 16.23B 140B 15.07B 14.75B 610B | 4.6B 4.37B 4.06B 3.6B 6.52B 390B 7.21B 50.44B 18.59B 160B 17.27B 16.89B 699B |
| Net income | 634M 602M 559M 496M 898M 53.76B 993M 6.95B 2.56B 22.08B 2.38B 2.33B 96.26B | 780M 741M 688M 611M 1.11B 66.16B 1.22B 8.55B 3.15B 27.18B 2.93B 2.86B 118B |
| Net Debt | 1.48B 1.41B 1.31B 1.16B 2.11B 126B 2.33B 16.28B 6B 51.75B 5.57B 5.45B 226B | 714M 678M 630M 559M 1.01B 60.58B 1.12B 7.83B 2.89B 24.88B 2.68B 2.62B 108B |
More financial data
* Estimated data
Employees
9,550
Calendar
2025-02-05
- Q4 2024 Earnings Release (Projected)
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-10 | 79.41 $ | +1.28% | 2,969,863 |
| 24-12-09 | 78.41 $ | +0.89% | 2,288,040 |
| 24-12-06 | 77.72 $ | -1.52% | 2,645,420 |
| 24-12-05 | 78.92 $ | -2.58% | 3,275,903 |
| 24-12-04 | 81.01 $ | +0.12% | 3,229,957 |
Delayed Quote Nasdaq, December 10, 2024 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
BUY
Number of Analysts
25
Last Close Price
78.41USD
Average target price
95.68USD
Spread / Average Target
+22.03%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition